Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A closer look at the role of apology in error disclosure: a simulation study.

Frontiers in health services·2025

Same author

Impact of the COVID-19 Pandemic on the Community Pharmacy Workforce.

Medical care research and review : MCRR·2023

Same author

Interprofessional Error Disclosure Training for Medical, Nursing, Pharmacy, Dental, and Physician Assistant Students.

MedEdPORTAL : the journal of teaching and learning resources·2019

Same author

Interprofessional education and practice guide: interprofessional team writing to promote dissemination of interprofessional education scholarship and products.

Journal of interprofessional care·2018

Same author

Choice of atypical antipsychotic therapy for patients with schizophrenia: An analysis of a medicaid population.

Current therapeutic research, clinical and experimental·2014

Same author

Medication adherence program: adherence challenges and interventions in type 2 diabetes.

Journal of the American Pharmacists Association : JAPhA·2013

Search research articles

Related Experiment Videos

MAP study: RCT of a medication adherence program for patients with type 2 diabetes.

Peggy Soule Odegard¹, Dale B Christensen

¹School of Pharmacy, University of Washington, Seattle, USA. podegard@u.washington.edu

Journal of the American Pharmacists Association : Japha

|December 12, 2012

Summary

This summary is machine-generated.

Community pharmacy interventions effectively improved diabetes medication adherence. A brief missed refill program enhanced medication possession ratio (MPR) for patients with diabetes, especially those with lower baseline adherence.

Related Experiment Videos

Area of Science:

Pharmacoeconomics and Health Outcomes Research
Clinical Pharmacy and Practice
Diabetes Mellitus Management

Background:

Medication adherence is crucial for managing diabetes and preventing complications.
Community pharmacy-based interventions offer accessible opportunities to improve patient adherence.
Identifying and addressing medication refill gaps is a key strategy for enhancing adherence.

Purpose of the Study:

To evaluate the effectiveness of a community pharmacy-based protocol for detecting and intervening in medication non-adherence among diabetic patients.
To assess the impact of pharmacist-led adherence support on medication possession ratio (MPR) in patients with diabetes.

Main Methods:

A randomized controlled trial was conducted in four urban community chain pharmacies.
Patients with diabetes (n=265) on oral medications, identified as late for refills, received telephone-initiated adherence support from pharmacists.
Medication adherence was measured using MPR at 6 and 12 months.

Main Results:

The intervention group showed a significant improvement in MPR at 12 months compared to the control group (P=0.01).
The intervention was particularly effective for patients with a baseline MPR below 80% (P=0.02).
Patients in the intervention group had a significantly higher likelihood of achieving an MPR above 80% at 12 months (OR 4.77).

Conclusions:

A brief missed refill intervention program in community pharmacies effectively improved diabetes medication adherence.
The intervention demonstrated particular benefit for patients with lower baseline medication possession ratios.
Community pharmacy-based adherence support represents a valuable strategy for optimizing diabetes care.